micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome

Rare Disease

MONDO:0014892

Also known as:

MEBASMRD44autosomal dominant intellectual disability 44

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome

0 approved

Organizations with approved therapies for this disease

No approved therapies yet

Research is ongoing — 4 companies have orphan drug designations for this disease

Berlex Laboratories, Inc.

Other

Designated

Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company

Other

Designated

Novartis Pharmaceutical Corporation

Other

Designated

Novartis Pharmaceuticals Corporation

Other

Designated

View all companies active in micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases

micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome

Patient-Friendly Information

Companies Active in micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome

Need this data in your product?

Scientific Intelligence